Can improving SCFAs prevent post-GLP-1 weight regain
If you miss a dose of liraglutide (Victoza or Saxenda), take the next usual dose the next day
Semaglutide provides a sustainable, long-term solution that repairs metabolic function
Results reveal your genetic predisposition to slow gastric emptying, acid sensitivity, and medication response, allowing your clinician to customize dosing and supportive care to minimize reflux while maximizing weight loss
One in five women, or 20%, reported having ever used GLP-1 agonists. Further, many GLP-1 users report side effects like nausea and diarrhea, the survey found
Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts